Cell programming

Boston-based Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has launched Bioworks7, the latest expansion of its biological engineering foundry.   With this new space, Ginkgo’s increased capacity will serve partners in cell and gene therapy, biomanufacturing and general mammalian programming for therapeutic applications and new biopharmaceutical modalities.  Context   Ginkgo’s foundry automates […]

Cronos Group and Ginkgo Bioworks have achieved the first target productivity milestone in their partnership to produce eight cultured cannabinoids.   Using Ginkgo’s platform for organism design and development, Cronos Group has successfully achieved the productivity target for cannabigerolic acid (CBGA), which will support Cronos Group’s planned CBG product launch this fall.   Launched in 2018 with the goal of accessing […]